Ocugen (NASDAQ:OCGN) gapped down prior to trading on Tuesday . The stock had previously closed at $0.58, but opened at $0.56. Ocugen shares last traded at $0.41, with a volume of 5,873,600 shares traded.
Separately, ValuEngine upgraded shares of Ocugen from a “hold” rating to a “buy” rating in a report on Friday, November 1st.
The firm has a market capitalization of $8.95 million, a P/E ratio of -0.01 and a beta of 2.92.
Ocugen Company Profile (NASDAQ:OCGN)
Ocugen, Inc, a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. The company offers an ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules, as well as targets a range of retinal and ocular surface diseases.
Featured Story: What is Depreciation?
Receive News & Ratings for Ocugen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ocugen and related companies with MarketBeat.com's FREE daily email newsletter.